These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease. Jolain B; Pettitt D Clin Ther; 1995; 17(3):572-80. PubMed ID: 7585861 [No Abstract] [Full Text] [Related]
3. Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens. Ginsberg HN Clin Cardiol; 1995 Jun; 18(6):307-15. PubMed ID: 7664504 [TBL] [Abstract][Full Text] [Related]
4. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy. Isles CG; Paterson JR QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551 [TBL] [Abstract][Full Text] [Related]
10. Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors. Tachibana-Iimori R; Tabara Y; Kusuhara H; Kohara K; Kawamoto R; Nakura J; Tokunaga K; Kondo I; Sugiyama Y; Miki T Drug Metab Pharmacokinet; 2004 Oct; 19(5):375-80. PubMed ID: 15548849 [TBL] [Abstract][Full Text] [Related]
11. Economics of lipid lowering with HMG CoA reductase inhibitors. Illingworth DR Clin Cardiol; 1995 Jun; 18(6):295, 363. PubMed ID: 7664501 [No Abstract] [Full Text] [Related]
12. Effectiveness of lipid lowering drugs in general practice: article illustrates major problem. Wang TW; Livingstone CA; Ferns GA BMJ; 2003 Jul; 327(7405):50-1; author reply 51. PubMed ID: 12842961 [No Abstract] [Full Text] [Related]
13. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease. Borgia MC; Medici F Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525 [TBL] [Abstract][Full Text] [Related]
14. Current and future treatment of hyperlipidemia: the role of statins. Farnier M; Davignon J Am J Cardiol; 1998 Aug; 82(4B):3J-10J. PubMed ID: 9737640 [TBL] [Abstract][Full Text] [Related]
15. The pharmacology and therapeutics of lipid-lowering drugs. Hunninghake DB Am Pharm; 1987 Nov; NS27(11):S18-25. PubMed ID: 3425537 [No Abstract] [Full Text] [Related]
16. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]]. Tomiyama H; Doba N Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101 [No Abstract] [Full Text] [Related]
17. Targeted prevention of coronary artery disease: pharmacological considerations in multimodality treatment. Shviro I; Leitersdorf E Cardiology; 1996; 87(6):469-75. PubMed ID: 8904672 [TBL] [Abstract][Full Text] [Related]